TARA Earnings Date: Nov 9, 2026 (Estimated) — Protara Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is TARA's next earnings date?
Protara Therapeutics, Inc. (TARA) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.37.
How did TARA do in its last earnings report?
In its most recent report on Aug 11, 2026 (Q2 2026), Protara Therapeutics, Inc. posted EPS of -$0.36 versus the -$0.33 estimate, a miss of 12.5%. Revenue was $0. The stock's 1-day post-earnings move was -4.9%.
How much does TARA stock move after earnings?
TARA beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.6% (up or down) in the day after earnings.
About Protara Therapeutics, Inc.
Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of lymphatic malformations. Furthermore, Protara is developing intravenous choline chloride, a potential phospholipid substrate replacement therapy aimed at addressing liver disease associated with intestinal failure. The organization, which was formerly known as ArTara Therapeutics, Inc., underwent a name change to Protara Therapeutics, Inc. in May 2020. Its principal operations are based in New York, New York.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 | Q2 2026 | -0.33 | -0.36 | -12.50% | $0 | ❌ Miss | -4.87% | -3.16% | -6.81% |
| 2026-05-13 | Q1 2026 | -0.37 | -0.31 | +16.22% | $0 | ✅ Beat | +0.97% | -15.73% | -29.13% |
| 2026-03-10 | Q4 2025 | -0.32 | -0.37 | -15.62% | $0 | ❌ Miss | -0.70% | -5.74% | -9.22% |
| 2025-11-10 | Q3 2025 | -0.40 | -0.31 | +22.50% | $0 | ✅ Beat | +5.59% | +28.44% | +33.80% |
| 2025-08-11 | Q2 2025 | -0.40 | -0.35 | +12.50% | $0 | ✅ Beat | -0.96% | -3.19% | -0.64% |
| 2025-03-05 | Q4 2024 | -0.56 | -0.48 | +14.29% | $0 | ✅ Beat | +8.04% | +22.02% | +27.68% |
| 2024-11-12 | Q3 2024 | -0.52 | -0.50 | +3.85% | $0 | ✅ Beat | +0.00% | -10.47% | +142.25% |
| 2024-08-06 | Q2 2024 | -0.80 | -0.45 | +43.75% | $0 | ✅ Beat | +0.00% | -6.28% | -6.76% |
Showing last 8 quarters.